Your session is about to expire
← Back to Search
Arthroscopic Stabilization vs Latarjet Procedure for Shoulder Dislocation (STABLE-2 Trial)
STABLE-2 Trial Summary
This trial tests if two shoulder repair surgeries have different effects on recovery time and function 24 months later.
STABLE-2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.STABLE-2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have epilepsy or a seizure disorder.I have had shoulder surgery in the past.My shoulder has dislocated at least twice due to injury.I have been diagnosed with joint instability in multiple directions.I am between 18 and 50 years old.I have mild shoulder socket bone loss (10-20%).
- Group 1: Bankart + Remplissage Procedure
- Group 2: Latarjet Procedure
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the enrollment of elderly participants being welcomed in this experiment?
"The participants accepted into this study must fall between 18 to 50 years old. For those outside of this age range, there are 31 studies for minors and 30 trials catered towards older adults."
Are there still opportunities available for individuals to enter this trial?
"According to clinicaltrials.gov, this medical trial is not actively recruiting new candidates at present. The study was initially posted on May 1st 2023 and the latest update occurred on January 27th of that same year. Despite this, there are still 61 other trials seeking participants currently listed online."
Is there a possibility for me to participate in this experiment?
"This clinical trial is seeking 126 participants aged 18-50 with a diagnosis of recurrent anterior shoulder dislocation. To meet the eligibility requirements, male and female patients must have experienced at least two episodes of dislocations indicated by radiographic evidence or physical examination as well as CT showing mild glenoid bone loss (<20%). In addition, all individuals must provide written consent to participate in the study."
Share this study with friends
Copy Link
Messenger